TCR2 Therapeutics
IPO News: TCR2 Therapeutics Prices 5mm Share IPO at $15, at the midpoint of the $14.00 - $16.00 Marketing Range
TCR2 Therapeutics

TCR2 Therapeutics

NASDAQ: TCRR

Initial Filing Date: 12/28/19

Launch Date: 02/01/19

Pricing Date: 02/13/19

IPO Price: $15.00

Price Range: $14.00 - $16.00

Initial Shares Offered (mm): 5.0

Shares Offered (Pre-Shoe | mm): 5.0

Primary Shares (mm): 5.0

Secondary Shares (mm): 0.0

Amount Offered (mm): $75.0

% Secondary: 0.0%

Shares Outstanding (mm): 23.2

Market Value at Pricing (mm): $347.8

Offering as % of Market Value: 21.6%

Bookrunners: JEFF | LEER | BMO

Co-Manager s: Wedbush Pacgrow | China Renaissance

Major Holders:  MPM Capital | F2 Capital | UBS Oncology Impact Fund | Cathay Fortune Corporation | 6 dimensions Capital | Mirae Asset 

Industry: Healthcare

Description: TCR2 Therapeutics is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.

Note: Emerging Growth Company

Reference Link: Press Release